日本喜固郎（HCG）人絨毛膜促性腺激素注射劑5000單位「F」

日本喜固郎（HCG）人絨毛膜促性腺激素注射劑5000單位「F」

日本喜固郎（HCG）人絨毛膜促性腺激素注射劑5000單位「F」, known in Japan as 注射用HCG5,000単位「F」, is a prescription hormone medicine from Fuji Pharma Co., Ltd.

It contains human chorionic gonadotrophin (hCG) derived from the urine of pregnant women. It is a medicine for selected reproductive and endocrine indications, not a cosmetic, placenta skincare product, or general wellness supplement.

產品資訊：

• 日文名稱： 注射用HCG5,000単位「F」
• 製造商： Fuji Pharma Co., Ltd. / 富士製薬工業株式会社
• 活性成分： Human Chorionic Gonadotrophin (hCG)
• 強度: 5,000 units per medicine ampoule
• 形式： Lyophilized preparation for injection
• Manufacturer Pack: 10 medicine ampoules with 10 separate 1mL physiological saline diluent ampoules
• Actual Sales Unit: Confirm with the seller
• Prescription Status: Prescription-only medicine in Japan

What Is HCG 5000 Units “F”?

HCG is a gonadotrophin hormone medicine. Whether this product is appropriate depends on the diagnosed condition, the relevant approved indication, and the prescribing clinician’s assessment.

主要特點

• 5,000-unit ampoule strength
• Freeze-dried medicine supplied with separate diluent
• Requires reconstitution before administration
• Requires a prescription and indication-specific monitoring

Japanese Labeled Medical Uses

Examples include anovulatory disorders, functional uterine bleeding, luteal insufficiency or luteal support in assisted reproduction, cryptorchidism, selected male infertility conditions, and reproductive function testing. This is not the complete indication list.

The 5,000-unit presentation also has Japanese indications for follicular maturation and luteinization in assisted reproductive technology, and ovulation induction and luteinization in general infertility treatment.

建議用法

The prescriber must determine the dose, route, timing, and treatment schedule. The strength printed on the ampoule is not a universal prescribed dose.

Do not select or change a regimen using this product page. Do not substitute another strength without prescriber confirmation.

Suggested Medical Setting

• Licensed reproductive medicine services
• Appropriate endocrine or urological medical services
• Authorized prescription dispensing services

Self-Administration

For specific labeled fertility indications, home subcutaneous administration may be considered by the treating physician. It requires a prescription, suitability assessment, practical training, and instructions on safe sharps disposal. This is not permission for unsupervised self-injection.

Monitoring and Aftercare

Attend the monitoring arranged by the treating clinic. Promptly report abdominal pain or swelling, nausea, rapid weight gain, or reduced urine output. Seek urgent medical attention for breathing difficulty, collapse, or a suspected severe reaction.

Who Should Avoid Use?

Contraindications include androgen-dependent malignancy or suspected malignancy, previous hypersensitivity to gonadotrophins, and precocious puberty. Active thromboembolic disease is also contraindicated for specified fertility indications.

This is not a complete screening checklist. Provide the prescriber with your medical history and medication list before treatment.

預防措施

• Serious risks include shock and ovarian hyperstimulation syndrome (OHSS).
• Severe OHSS may involve thromboembolic complications.
• Ovulation-induction treatment may increase the likelihood of multiple pregnancy.
• Read the complete official prescribing and patient information.
• Do not use damaged or expired ampoules.

儲存說明

• Store at 1–15°C, protected from light.
• Avoid freezing.
• 請將本品放在兒童不能接觸的地方。
• Reconstitute immediately before use according to the official instructions.

Package Contents

The manufacturer pack contains ten 5,000-unit medicine ampoules and ten 1mL saline diluent ampoules. Confirm the actual listing quantity, batch number, and expiry before supply.

重要免責聲明

This page is a product reference, not an individualized treatment plan. Official labeling and the treating clinician’s instructions take precedence. No pregnancy or other treatment outcome is guaranteed.

Before enabling purchases, verify the destination-specific requirements for prescription supply, importation, advertising, and dispensing. Do not present this medicine as an anti-aging, weight-management, or unrestricted wellness product.